早盘AI医疗概念震荡回升，华人健康涨近15%，此前鹭燕医药2连板，美年健康、安必平、成都先导、 塞力医疗跟涨。 ...

近日该股表现 | 日期 | 当日涨跌幅（%） | 换手率（%） | 主力资金净流入（万元） | | --- | --- | --- | --- | | 2025.12.18 | 9.97 | 1.89 | 1629.16 | | 2025.12.17 | 10.01 | 18.36 | 8165.97 | | 2025.12.16 | 4.45 | 18.26 | 6426.90 | | 2025.12.15 | -1.61 | 7.45 | 1222.98 | | 2025.12.12 | 6.27 | 10.48 | 6053.09 | | 2025.12.11 | -4.71 | 8.99 | -2780.83 | | 2025.12.10 | -1.34 | 11.90 | -248.81 | | 2025.12.09 | -1.15 | 14.18 | 649.15 | | 2025.12.08 | 4.04 | 18.37 | -2327.50 | | 2025.12.05 | 6.98 | 18.18 | 11940.49 | （文章来源：证券时报网） 鹭燕医药盘中涨停，已连收3个涨停板，截至9 ...

今日关注 申购提示：今日3只新股申购。 商务部：已批准部分稀土出口通用许可申请。 10．当地时间18日，英国央行英格兰银行宣布，将基准利率由此前的4%下调至3.75%。这是2024年8月 以来的第6次降息，也是英国自2023年2月以来的最低基准利率。 4．商务部新闻发言人何亚东在12月18日举行的例行新闻发布会上说，中方注意到，欧委会近期密集对 中国企业发起《外国补贴条例》（FSR）调查，先后对中车集团、同方威视发起深入调查，甚至对中国 数字平台进行现场突袭检查，做法恶劣，指向性和歧视性明显。中方对此强烈反对。希望欧方立即停止 对包括中国在内的外国投资企业的无理打压，审慎使用FSR调查工具，为在欧投资经营企业创造公平、 公正、可预期的营商环境。中方密切关注欧方有关动向，将采取必要措施，坚决维护中国企业合法权 益。 5．香港交易所于12月18日刊发《优化香港证券市场每手买卖单位框架》的咨询文件，主要包含以下三 个部分：1.将每手价值的指引下限从2000港元降至1000港元。2.增设50000港元的每手价值指引上限。3. 将每手股数的种类减至八种标准化的选项：1股、50股、100股、500股、1000股、2000 ...

Group 1 - New stock offerings include Qiangyi Co. with an issuance price of 85.09 CNY per share and a subscription limit of 0.75 million shares, Yufan Technology at 22.29 CNY per share with a limit of 0.85 million shares, and Shuangxin Environmental Protection at 6.85 CNY per share with a limit of 60 million shares [2] - The Ministry of Commerce announced that some Chinese exporters have met the basic requirements for applying for general licenses regarding rare earth export controls, with some applications already approved [3] - The Hong Kong Stock Exchange is proposing a new trading unit framework to enhance market efficiency and reduce investment thresholds, which includes lowering the minimum value for trading units from 2000 HKD to 1000 HKD [4] Group 2 - The State Council issued guidelines to combat illegal activities related to tobacco, aiming to address issues such as counterfeiting and smuggling [4] - The State-owned Assets Supervision and Administration Commission released measures for accountability in investment violations, categorizing asset losses and defining responsibilities based on severity [5] - The Ministry of Industry and Information Technology announced that the photovoltaic industry will enter a critical governance phase by 2026, focusing on capacity regulation and management of manufacturing projects [5] Group 3 - The Bank of England announced a reduction in the benchmark interest rate from 4% to 3.75%, marking the lowest rate since February 2023 [6] - Haitian Flavor Industry plans to distribute a special dividend of 3 CNY per share [8] - Sichuan Road and Bridge has been acquired by Zhongyou Insurance, reaching a 5% shareholding [8]

证券之星消息，根据市场公开信息整理，12月18日鹭燕医药（002788）新增【AI医疗】概念。 鹭燕医药2025年三季报显示，前三季度公司主营收入158.55亿元，同比上升2.87%；归母净利润2.2亿 元，同比下降14.64%；扣非净利润2.2亿元，同比下降15.14%；其中2025年第三季度，公司单季度主营 收入54.55亿元，同比上升6.81%；单季度归母净利润6513.66万元，同比下降2.74%；单季度扣非净利润 6666.89万元，同比下降7.93%；负债率74.98%，投资收益-1088.49万元，财务费用1.39亿元，毛利率 6.96%。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 新增概念原因：公司已形成智能诊断设备研发、医疗服务智能化升级、药品追溯智能化三大核心 AI 医 疗应用方向。 该公司关联的其它概念板块还包括：养老概念、人工智能、智能医疗、海峡西岸、冷链物流。 鹭燕医药（002788）主营业务：药品、中药饮片、医疗器械、疫苗等分销及医药零售连锁。 ...

今日聚焦 1、中微公司：筹划购买杭州众硅控股权 股票停牌 中微公司(688012)12月18日公告，公司正在筹划通过发行股份的方式购买杭州众硅电子科技有限公司(简 称"杭州众硅")控股权并募集配套资金，标的资产估值及定价尚未确定。经初步测算，本次交易不构成 重大资产重组。公司股票自12月19日(星期五)开市起开始停牌，预计停牌时间不超过10个交易日。中微 公司的主要产品是等离子体刻蚀和薄膜沉积设备，属于真空下的干法设备。杭州众硅所开发的是湿法设 备里面重要的化学机械抛光设备(CMP)。刻蚀、薄膜和湿法设备，是除光刻机以外最为核心的半导体工 艺加工设备。通过本次的并购，双方将形成显著的战略协同。 2、旗滨集团：控股子公司拟6亿元设立深圳新能源公司 旗滨集团(601636)12月18日公告，公司控股子公司旗滨光能拟在深圳市宝安区投资设立深圳旗滨新能源 科技有限公司(简称"深圳新能源")，深圳新能源注册资本6亿元，旗滨光能持股比例100%，并将以该平 台为抓手，全面梳理整合、优化提升光伏玻璃供应链的协同效率与管理水平，助力旗滨光能在行业竞争 中筑牢优势。 3、博盈特焊：公司生产的HRSG设备主要匹配重型燃气轮机 博 ...

（编辑 任世碧） 证券日报网讯 12月18日晚间，鹭燕医药发布公告称，公司股票交易价格连续两个交易日内（2025年12 月17日、2025年12月18日）收盘价格涨幅偏离值累计超过20%，属于股票交易异常波动的情况。经核 实，前期披露的信息不存在需要更正、补充之处；近期公司经营情况正常，内外部经营环境未发生重大 变化；公司未发现近期公共传媒报道了可能或已经对本公司股票交易价格产生较大影响的未公开重大信 息。 ...

Market Overview - The overall market sentiment is described as ordinary, with the ChiNext index showing a significant decline of 2.17% while the Shanghai Composite Index slightly increased by 0.16% [1] - Various sectors experienced mixed performances, with notable gains in AI healthcare and retail, while sectors like Hainan and lithium batteries faced declines [1] Reward Economy - The concept of "Reward Economy" has gained attention, defined as consumers purchasing non-essential items or experiences to alleviate work and life pressures, reflecting a growing trend among younger consumers [5][6] - The Chinese潮玩 (trendy toy) market is projected to reach a market size of 110.1 billion yuan by 2026, indicating substantial growth potential [6] AI Healthcare - AI healthcare stocks rebounded strongly, with companies like Luyuan Pharmaceutical and Meinian Health achieving consecutive gains, while the sector overall rose by 4.23% [11] - The catalyst for this surge was the recent upgrade of Ant Group's AI health app, "Antifufu," which has over 15 million monthly active users, positioning it as a leading health management AI app in China [11] Lithography Machine Sector - The lithography machine sector saw a strong opening, particularly for stocks like New Kylin, which experienced significant gains, although the sector ultimately closed down by 0.56% [14][15] Fujian Sector - The Fujian sector displayed mixed results, with strong performances from traditional leaders like Luyuan Pharmaceutical and Jiumu Wang, while other stocks faced declines [18] - The overall Fujian sector rose by 1.23%, contrasting with the Hainan sector, which saw a significant drop of 3.37% [18]

Market Overview - A total of 61 stocks hit the daily limit up, while 19 stocks faced limit down, resulting in a sealing rate of 76% [1] - The Shanghai Composite Index rose by 0.16%, while the Shenzhen Component Index and the ChiNext Index fell by 1.29% and 2.17% respectively [1] - The total trading volume in the Shanghai and Shenzhen markets was 1.66 trillion, a decrease of 155.7 billion from the previous trading day [1] Stock Performance - Baida Group achieved a six-day limit up streak, while Shengtong Energy and Pinao recorded five and four consecutive limit ups respectively [1][3] - The number of stocks advancing was nearly 2900, with notable performances in the pharmaceutical, banking, and retail sectors [1] - The commercial aerospace concept saw a resurgence, with stocks like Shunhao and Xibu Materials hitting limit up after previous declines [3][5] Sector Analysis - The pharmaceutical commercial sector experienced significant growth due to increased orders amid a rise in respiratory diseases during the winter season [14][15] - The retail sector, particularly driven by the "reward economy," showed strong performance with stocks like Baida Group and Nanjing Shanglv achieving consecutive limit ups [6][12] - The AI healthcare sector remained active, with Ant Group's AI health app "Antifortune" gaining popularity, leading to limit ups for companies like Meian Health and Huaren Health [7][19] Investment Themes - The commercial aerospace sector is highlighted as a strategic emerging industry, with government support and recent rocket launches boosting investor sentiment [5] - The "reward economy" is emerging as a new consumption model among younger demographics, contributing to the growth of related sectors [6][12] - The IP economy is gaining traction, with government initiatives aimed at promoting new consumption models and financial support for innovative businesses [16] Future Outlook - The market is expected to continue experiencing volatility, with a focus on small-cap stocks and growth sectors as larger stocks face profit-taking [9] - The Shanghai Composite Index is attempting to recover above key moving averages, indicating potential for further upward movement if trading volume increases [9]

每经AI快讯，12月18日，鹭燕医药(002788.SZ)公告称，公司股票交易价格连续两个交易日内收盘价格 涨幅偏离值累计超过20%，属于股票交易异常波动的情况。经核实，公司前期披露的信息不存在需要更 正、补充之处，近期公司经营情况正常，内外部经营环境未发生重大变化，公司、控股股东和实际控制 人不存在关于本公司的应披露而未披露的重大事项，或处于筹划阶段的重大事项。股票异常波动期间， 控股股东、实际控制人不存在买卖公司股票的情形。 ...